Trial intelligence / Profile preview

Cyclopofol ED50 with alfentanil for pediatric fiberoptic bronchoscopy

ChiCTR2500095988Phase 4Not yet recruiting

Sponsor
Ganzhou Maternal and Child Health Hospital
Start
Jan 2025
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ciprofol and alfentanil in pneumonia (2 arms), sponsored by Ganzhou Maternal and Child Health Hospital. Primary endpoints: Occurrence of coughing reaction, Heart rate and 2 more. Planned start Jan 2025; status: not yet recruiting.

02

Drugs

ciprofolalfentanil
03

Conditions

pneumonia

Beyond the preview

Go deeper on ChiCTR2500095988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500095988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call